Loading...
Loading...
Vertex Pharmaceuticals Inc · Biotechnology
Small/Mid Cap
Vertex Pharmaceuticals Inc's TraderMatrix Quality Score is 92/100 (High quality), a 0–100 read on profitability, valuation, balance-sheet safety, growth and (for dividend payers) payout safety. Vertex Pharmaceuticals Inc is a Biotechnology company in the small/mid cap tier.
VRTX ranks #2 of 32 in the Biotechnology sector by Quality Score. Closest scores:
Quality Score is a 0–100 composite rating blending profitability, valuation, balance-sheet safety, growth and (for dividend payers) payout safety. Higher scores indicate stronger fundamental characteristics. Use it to screen out weak names before selling premium or buying LEAPS. Read the full methodology.
Vertex Pharmaceuticals Inc has a TraderMatrix Quality Score of 92/100, which falls in the "High quality" band. It ranks #2 of 32 in the Biotechnology sector. Scores of 80+ are rated High quality, 65–79 Solid, 50–64 Mixed and below 50 Weak. This is a fundamentals read, not investment advice.
The Quality Score is a 0–100 composite that blends profitability, valuation, balance-sheet safety, growth and (for dividend payers) payout safety into one number. VRTX's current score is 92/100.
The score is recalculated as new data arrives. VRTX's score of 92/100 was last updated on Oct 13, 2026.
Updated Oct 13, 2026